Global Pathogen Analysis Service Ltd
Corinna Bull is currently serving as the Acting Chief Operating Officer at Global Pathogen Analysis Service Ltd, a health tech start-up focused on utilizing pathogen genomics to combat infectious diseases. With a background in corporate affairs and healthcare policy consulting, Corinna has also held various leadership positions at Eli Lilly and Company. Additionally, Corinna has experience as an Associate at Bright Blue, an independent think tank. Corinna began their career as a Researcher at the House of Commons and has a Bachelor of Arts degree in Politics from Durham University.
This person is not in any teams
This person is not in any offices
Global Pathogen Analysis Service Ltd
The Global Pathogen Analysis System (GPAS) aims to improve global health by providing rapid, accessible and standardised genomic analysis for a range of pathogens, starting with SARS-CoV-2. Built by a long-established world-leading pathogen genomics team from Oxford University, supported by the cloud computing scale and security of Oracle Inc. GPAS is a global, turn-key solution that systematises how data from genomic sequencing is processed. Building on our successful SARS-CoV-2 toolset, GPAS will scale rapidly to analyse a range of pathogens, including M. tuberculosis, and deliver these solutions to laboratories, hospitals and public health organisations around the globe.